130 related articles for article (PubMed ID: 10361132)
1. The human (PsiL+mu-) proB complex: cell surface expression and biochemical structure of a putative transducing receptor.
Lemmers B; Gauthier L; Guelpa-Fonlupt V; Fougereau M; Schiff C
Blood; 1999 Jun; 93(12):4336-46. PubMed ID: 10361132
[TBL] [Abstract][Full Text] [Related]
2. Mu-surrogate light chain physicochemical interactions of the human preB cell receptor: implications for VH repertoire selection and cell signaling at the preB cell stage.
Gauthier L; Lemmers B; Guelpa-Fonlupt V; Fougereau M; Schiff C
J Immunol; 1999 Jan; 162(1):41-50. PubMed ID: 9886368
[TBL] [Abstract][Full Text] [Related]
3. Fine characterization of childhood and adult acute lymphoblastic leukemia (ALL) by a proB and preB surrogate light chain-specific mAb and a proposal for a new B cell ALL classification.
Lemmers B; Arnoulet C; Fossat C; Chambost H; Sainty D; Gabert J; Schiff C
Leukemia; 2000 Dec; 14(12):2103-11. PubMed ID: 11187899
[TBL] [Abstract][Full Text] [Related]
4. Structure, biosynthesis, and transduction properties of the human mu-psi L complex: similar behavior of preB and intermediate preB-B cells in transducing ability.
Bossy D; Salamero J; Olive D; Fougereau M; Schiff C
Int Immunol; 1993 May; 5(5):467-78. PubMed ID: 8318451
[TBL] [Abstract][Full Text] [Related]
5. A complex of glycoproteins is associated with VpreB/lambda 5 surrogate light chain on the surface of mu heavy chain-negative early precursor B cell lines.
Karasuyama H; Rolink A; Melchers F
J Exp Med; 1993 Aug; 178(2):469-78. PubMed ID: 8340754
[TBL] [Abstract][Full Text] [Related]
6. B lymphocyte development in rabbit: progenitor B cells and waning of B lymphopoiesis.
Jasper PJ; Zhai SK; Kalis SL; Kingzette M; Knight KL
J Immunol; 2003 Dec; 171(12):6372-80. PubMed ID: 14662835
[TBL] [Abstract][Full Text] [Related]
7. Cell surface expression of surrogate light chain (psi L) in the absence of mu on human pro-B cell lines and normal pro-B cells.
Meffre E; Fougereau M; Argenson JN; Aubaniac JM; Schiff C
Eur J Immunol; 1996 Sep; 26(9):2172-80. PubMed ID: 8814264
[TBL] [Abstract][Full Text] [Related]
8. Discrete early pro-B and pre-B stages in normal human bone marrow as defined by surface pseudo-light chain expression.
Guelpa-Fonlupt V; Tonnelle C; Blaise D; Fougereau M; Fumoux F
Eur J Immunol; 1994 Jan; 24(1):257-64. PubMed ID: 8020565
[TBL] [Abstract][Full Text] [Related]
9. Kinetic analysis of the interactions of recombinant human VpreB and Ig V domains.
Hirabayashi Y; Lecerf JM; Dong Z; Stollar BD
J Immunol; 1995 Aug; 155(3):1218-28. PubMed ID: 7636190
[TBL] [Abstract][Full Text] [Related]
10. The Ig alpha/Igbeta heterodimer on mu-negative proB cells is competent for transducing signals to induce early B cell differentiation.
Nagata K; Nakamura T; Kitamura F; Kuramochi S; Taki S; Campbell KS; Karasuyama H
Immunity; 1997 Oct; 7(4):559-70. PubMed ID: 9354476
[TBL] [Abstract][Full Text] [Related]
11. Surrogate light chain production during B cell differentiation: differential intracellular versus cell surface expression.
Wang YH; Nomura J; Faye-Petersen OM; Cooper MD
J Immunol; 1998 Aug; 161(3):1132-9. PubMed ID: 9686571
[TBL] [Abstract][Full Text] [Related]
12. The roles of preB cell receptor in early B cell development and its signal transduction.
Karasuyama H; Nakamura T; Nagata K; Kuramochi T; Kitamura F; Kuida K
Immunol Cell Biol; 1997 Apr; 75(2):209-16. PubMed ID: 9107579
[TBL] [Abstract][Full Text] [Related]
13. Analysis of VpreB expression during B lineage differentiation in lambda5-deficient mice.
Stephan RP; Elgavish E; Karasuyama H; Kubagawa H; Cooper MD
J Immunol; 2001 Oct; 167(7):3734-9. PubMed ID: 11564789
[TBL] [Abstract][Full Text] [Related]
14. Identification of candidate target antigens for antibody-based immunotherapy in childhood B-cell precursor ALL.
Gudowius S; Recker K; Laws HJ; Dirksen U; Tröger A; Wieczorek U; Furlan S; Göbel U; Hanenberg H
Klin Padiatr; 2006; 218(6):327-33. PubMed ID: 17080335
[TBL] [Abstract][Full Text] [Related]
15. Pre-B-cell development in the absence of lambda 5 in transgenic mice expressing a heavy-chain disease protein.
Corcos D; Dunda O; Butor C; Cesbron JY; Lorès P; Bucchini D; Jami J
Curr Biol; 1995 Oct; 5(10):1140-8. PubMed ID: 8548286
[TBL] [Abstract][Full Text] [Related]
16. The VpreB protein of the surrogate light-chain can pair with some mu heavy-chains in the absence of the lambda 5 protein.
Seidl T; Rolink A; Melchers F
Eur J Immunol; 2001 Jul; 31(7):1999-2006. PubMed ID: 11449352
[TBL] [Abstract][Full Text] [Related]
17. A truncated heavy chain protein relieves the requirement for surrogate light chains in early B cell development.
Shaffer AL; Schlissel MS
J Immunol; 1997 Aug; 159(3):1265-75. PubMed ID: 9233622
[TBL] [Abstract][Full Text] [Related]
18. Disruption of the preB Cell Receptor Complex Leads to Decreased Bone Mass.
Khass M; Rashid H; Burrows PD; Bridges SL; Javed A; Schroeder HW
Front Immunol; 2019; 10():2063. PubMed ID: 31552025
[TBL] [Abstract][Full Text] [Related]
19. A human non-XLA immunodeficiency disease characterized by blockage of B cell development at an early proB cell stage.
Meffre E; LeDeist F; de Saint-Basile G; Deville A; Fougereau M; Fischer A; Schiff C
J Clin Invest; 1996 Oct; 98(7):1519-26. PubMed ID: 8833898
[TBL] [Abstract][Full Text] [Related]
20. Pre-B cell receptor-mediated selection of pre-B cells synthesizing functional mu heavy chains.
Kline GH; Hartwell L; Beck-Engeser GB; Keyna U; Zaharevitz S; Klinman NR; Jäck HM
J Immunol; 1998 Aug; 161(4):1608-18. PubMed ID: 9712022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
